Acne vulgaris.
Purdy
Sarah
S
University of Newcastle, Newcastle upon Tyne, UK.
D000152:Acne Vulgaris / Q000188:drug therapy*; D000068816:Adapalene; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001585:Benzoyl Peroxide / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D003998:Dicarboxylic Acids / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D008911:Minocycline / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014212:Tretinoin / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D003998:Dicarboxylic Acids; D009281:Naphthalenes; D000068816:Adapalene; D002981:Clindamycin; D014212:Tretinoin; D004917:Erythromycin; D015474:Isotretinoin; C010038:azelaic acid; D013752:Tetracycline; D008911:Minocycline; D015032:Zinc; D004318:Doxycycline; D001585:Benzoyl Peroxide